RESUMEN
Patients seeking medical care with erythema migrans or flu-like symptoms after suspected or observed tick bite in the southeast of Sweden and previously investigated for Borrelia spp. and/or Anaplasma sp. were retrospectively examined for serological evidence of rickettsial infection (Study 1). Twenty of 206 patients had IgG and/or IgM antibodies to Rickettsia spp. equal to or higher than the cut-off titre of 1:64. Seven of these 20 patients showed seroconversion indicative of recent or current infection and 13 patients had titres compatible with past infection, of which five patients were judged as probable infection. Of 19 patients with medical records, 11 were positive for Borrelia spp. as well, and for Anaplasma sp., one was judged as positive. Five of the 19 patients had antibodies against all three pathogens. Erythema migrans or rash was observed at all combinations of seroreactivity, with symptoms including fever, muscle pain, headache and respiratory problems. The results were compared by screening an additional 159 patients (Study 2) primarily sampled for the analysis of Borrelia spp. or Mycoplasma pneumoniae. Sixteen of these patients were seroreactive for Rickettsia spp., of which five were judged as recent or current infection. Symptoms of arthritis, fever, cough and rash were predominant. In 80 blood donors without clinical symptoms, approximately 1 % were seroreactive for Rickettsia spp., interpreted as past infection. The study shows that both single and co-infections do occur, which illustrate the complexity in the clinical picture and a need for further studies to fully understand how these patients should best be treated.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Infecciones por Rickettsiaceae/epidemiología , Rickettsieae/inmunología , Enfermedades por Picaduras de Garrapatas/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anaplasma/inmunología , Borrelia/inmunología , Comorbilidad , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Persona de Mediana Edad , Infecciones por Rickettsiaceae/inmunología , Infecciones por Rickettsiaceae/patología , Estudios Seroepidemiológicos , Suecia/epidemiología , Enfermedades por Picaduras de Garrapatas/inmunología , Enfermedades por Picaduras de Garrapatas/patología , Adulto JovenRESUMEN
In this paper we analyze spatial and temporal variations of air pollution (PM(1), PM(2.5), PM(10), CO, NO(x), O(3), Toluene and Benzene) and climate in areas of different development typology in Ouagadougou, Burkina Faso. Analyses are based on measurements from fixed sites and car traverse measurements during field studies in 2007 and 2010. Large spatial and temporal variations were found, showing a generally poor air quality situation, with extreme levels of PM(10), commonly exceeding air quality guidelines of WHO. Pollution levels increase considerably with increased atmospheric stability. Important sources were transported dust and re-suspension of dust from unpaved roads, but also traffic emissions and biomass burning. The spatial variations are examined with focus on effects for variations in potential exposure depending on for example area of residence and daily activity pattern, showing that great differences are likely to exist. Ouagadougou, like most developing countries worldwide, currently experiences an extremely rapid population growth in combination with limited financial means. This is likely to create increasingly harmful air pollution situations for the rapidly growing populations of these areas, and shows an urgent need for increased understanding of the pollution situation as well as development of mitigation strategies.
Asunto(s)
Contaminantes Atmosféricos/análisis , Contaminación del Aire/estadística & datos numéricos , Benceno/análisis , Burkina Faso , Monóxido de Carbono/análisis , Ciudades , Países en Desarrollo , Monitoreo del Ambiente , Óxidos de Nitrógeno/análisis , Ozono/análisis , Material Particulado/análisis , Crecimiento Demográfico , Tolueno/análisisRESUMEN
The spatial and temporal variations of PM(2.5), PM(10) and TSP in three African cities of different sizes (Dar es Salaam, Ouagadougou and Gaborone) were investigated using portable particle counters. Three different areas (downtown, green residential and traditional residential) and a reference site were designated in each of the cities in order to detect intra-urban and temporal variability. Morning, noon and night measurements were conducted in the urban areas while observations at reference stations were made continuously over the field periods. A clear diurnal pattern in particle concentrations was found in inland Gaborone and Ouagadougou, with morning and night peaks where the latter was the highest. However, in coastal Dar es Salaam the night peak was almost absent due to delayed stabilisation of the air. Particle concentrations at the Ouagadougou reference station were extreme. The direct contribution of vehicle emissions are of secondary importance since the PM(2.5)/PM(10) ratios are low (0.1-0.3). Much of the particles are supposed to be soil particles that are entrained in the air by daytime high windspeeds followed by nighttime subsidence as the air is stabilised and windspeed decreases. However, in all three cities, resuspension are important as areas with a network of unpaved roads showed the highest concentrations of suspended particles. Generally, the central business district had the lowest concentrations of particulate matter.
Asunto(s)
Movimientos del Aire , Ciudades , Monitoreo del Ambiente , Material Particulado/análisis , Estaciones del Año , África , Aire/análisis , Factores de TiempoRESUMEN
The aim of this study was to evaluate the synthetic C6 peptide test as a first-line test in a two-tiered scheme for Borrelia serology in a clinically well-characterized population of patients with Lyme borreliosis in Kalmar County, Sweden. The study population consisted of a prospective group (n = 200), a control group (n = 255), and a retrospective group (n = 29). The test panel consisted of the Immunetics Quick ELISA C6 Borrelia assay kit (Immunetics, Cambridge, MA, USA), the Virotech Borrelia burgdorferi ELISA (Genzyme Virotech, Rüsselsheim, Germany), and the Liaison Borrelia CLIA (DiaSorin, Saluggia, Vercelli, Italy). Seroprevalence among 200 healthy blood donors was significantly lower in the C6 test (8%) compared to the Virotech ELISA (14%) and the Liaison CLIA (12%). In convalescent sera (2-3 months and 6 months post infection) from 158 patients with erythema migrans, the seropositivity in the C6 test was also significantly lower compared to both the Virotech ELISA and the Liaison CLIA. Serosensitivity in the acute phase of erythema migrans and other clinical manifestations of borreliosis did not differ significantly between the C6 test and the Virotech ELISA or the Liaison CLIA. Overall, a positive C6 test seems to correlate well with acute borreliosis. Cross-reactivity was lower in the C6 test in sera positive for Epstein-Barr virus infection as compared to the Virotech ELISA. This study supports the use of the C6 test as a screening test for borreliosis, in endemic areas.
Asunto(s)
Borrelia burgdorferi/aislamiento & purificación , Enfermedad de Lyme/diagnóstico , Juego de Reactivos para Diagnóstico/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Ensayo de Inmunoadsorción Enzimática/métodos , Eritema Crónico Migrans/inmunología , Eritema Crónico Migrans/microbiología , Femenino , Humanos , Enfermedad de Lyme/inmunología , Masculino , Persona de Mediana Edad , Péptidos , Estudios Prospectivos , Estudios Retrospectivos , Sensibilidad y Especificidad , Pruebas Serológicas/métodosRESUMEN
Lyme borreliosis and human granulocytic ehrlichiosis are tick-borne diseases caused by Borrelia burgdorferi and Anaplasma phagocytophilum, respectively. Infection with A. phagocytophilum has been observed to induce immunosuppression and animal studies suggest that the bacteria might also have prolonged inhibitory effects on immune cells. The aim of this study was to investigate the cytokine secretion in patients exposed previously to A. phagocytophilum and currently infected with B. burgdorferi compared with patients infected with B. burgdorferi and seronegative for A. phagocytophilum. Eight patients with erythema migrans and antibodies against A. phagocytophilum, 15 patients with erythema migrans and negative A. phagocytophilum serology and 15 non-exposed healthy individuals were included in the study. Blood mononuclear cells were stimulated with Borrelia-antigen and the number of cytokine [interleukin (IL)-4, IL-5, IL-12, IL-13 and interferon (IFN)-gamma]-secreting cells was detected by enzyme-linked immunospot (ELISPOT). This study shows that patients with a previous exposure to A. phagocytophilum and a current infection with B. burgdorferi have a lower number of Borrelia-specific cells secreting IL-12 compared to Ap seronegative patients infected with B. burgdorferi (P < 0.001), indicating impairment in the ability to mount strong Th1-responses. We suggest that this mirrors a reduced Th1 response caused by A. phagocytophilum which could influence the outcome of the Borrelia infection and, speculatively, may also have implications in other conditions.
Asunto(s)
Anaplasma phagocytophilum/inmunología , Ehrlichiosis/inmunología , Interleucina-12/inmunología , Enfermedad de Lyme/inmunología , Adolescente , Adulto , Anciano , Anticuerpos Antibacterianos/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Eritema Crónico Migrans/inmunología , Femenino , Granulocitos/inmunología , Humanos , Interferón gamma/inmunología , Interleucina-13/inmunología , Interleucina-4/inmunología , Interleucina-5/inmunología , Masculino , Persona de Mediana EdadRESUMEN
AIMS: To genetically sub-type Campylobacter jejuni strains isolated from migratory birds, and to compare these with clinical strains collected in the same area and corresponding time period, with the aim to increase our knowledge on sub-types occurring among wild birds and their possible impact on human disease. METHODS AND RESULTS: We sub-typed C. jejuni strains from migrating birds (n = 89) and humans (n = 47), using macrorestriction profiling by pulsed-field gel electrophoresis. Isolates from migrant birds often exhibited sub-types with higher levels of similarity to isolates from birds of the same species or feeding guild, than to isolates from other groups of birds. Likewise, could the vast majority of sub-types found among the migrant bird isolates not be identified among sub-types from human cases. Only two bird strains, one from a starling (Sturnus vulgaris) and one from a blackbird (Turdus merula), had sub-types that were similar to some of the human strain sub-types. CONCLUSIONS: Isolates from one bird species, or feeding guild, often exhibited high similarities, indicating a common transmission source for individuals, or an association between certain sub-types of C. jejuni and certain ecological guilds or phylogenetic groups of birds. Sub-types occurring among wild birds were in general distinctively different from those observed in patients. The two bird isolates that were similar to human strains were isolated from bird species that often live in close associations with human settlements. SIGNIFICANCE AND IMPACT OF STUDY: Wild birds have often been mentioned as a potential route for transmission of C. jejuni to humans. Our study demonstrates that strains isolated from birds most often are different from clinical strains, but that some strain similarities occur, notably in birds strongly associated with human activities.
Asunto(s)
Enfermedades de las Aves/microbiología , Infecciones por Campylobacter/microbiología , Infecciones por Campylobacter/veterinaria , Campylobacter jejuni/genética , Genes Bacterianos , Animales , Animales Salvajes , Aves , Infecciones por Campylobacter/transmisión , Electroforesis en Gel de Campo Pulsado , Genotipo , Humanos , ZoonosisRESUMEN
The seroprevalence of granulocytic ehrlichiosis has been documented in several studies, but little data exists on incidence rates. Using sera stored from an earlier study on Lyme borreliosis, 290 residents of Aspö Island could be followed prospectively during two tick seasons (1992-1994). Immunoglobulin G antibodies to granulocytic ehrlichiosis were detected by an immunofluorescence assay using Ehrli- chia equi as antigen. Seroprevalence rates increased significantly over time, and at the 1994 follow-up, 28% of the residents were seropositive. Negative-to-positive seroconversion (incidence) rates were 3.9% and 11.1%, respectively, during the two seasons. A highly significant correlation was found between a positive serologic response for granulocytic ehrlichiosis and Borrelia burgdorferi. No such correlations were found for clinical Lyme borreliosis, self-reported arthralgia or number of recorded tick bites. It was concluded that granulocytic ehrlichiosis is highly endemic in this part of Sweden, with a seroconversion rate as high as 11% over a single tick season. Further studies are necessary to correlate these findings with clinical signs of human granulocytic ehrlichiosis.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Ehrlichia/inmunología , Ehrlichiosis/microbiología , Enfermedades por Picaduras de Garrapatas/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/sangre , Mordeduras y Picaduras de Insectos , Masculino , Persona de Mediana Edad , Estudios SeroepidemiológicosRESUMEN
In the twelve clinical cases of human granulocytic ehrlichiosis (HGE) so far identified in Scandinavia (ten in Sweden, two in Norway), clinical presentation varied from a mild febrile illness to a severe septic condition with such systemic complications as acute respiratory distress syndrome (ARDS). Laboratory verification was based on PCR (polymerase chain reaction) in ten cases, and on serology in two cases. Sequence analysis of 16S rDNA showed the infectious agents to belong to the Ehrlichia phagocytophila genogroup. Seroprevalence data indicate widespread human exposure to granulocytic Ehrlichia; mean seroprevalence, 15-20% of 1,000 clinical sera from tick-exposed patients (mainly from Sweden and Norway). Proposals for diagnostic criteria and procedures, and case management are presented in the article.
Asunto(s)
Ehrlichiosis , Complicaciones Parasitarias del Embarazo/diagnóstico , Enfermedades por Picaduras de Garrapatas , Zoonosis , Adulto , Animales , Anticuerpos Antibacterianos/análisis , Diagnóstico Diferencial , Ehrlichia/clasificación , Ehrlichia/inmunología , Ehrlichiosis/diagnóstico , Ehrlichiosis/tratamiento farmacológico , Ehrlichiosis/epidemiología , Ehrlichiosis/transmisión , Femenino , Guías como Asunto , Humanos , Reacción en Cadena de la Polimerasa , Embarazo , Complicaciones Parasitarias del Embarazo/tratamiento farmacológico , Suecia/epidemiología , Enfermedades por Picaduras de Garrapatas/diagnóstico , Enfermedades por Picaduras de Garrapatas/tratamiento farmacológico , Enfermedades por Picaduras de Garrapatas/epidemiología , Enfermedades por Picaduras de Garrapatas/transmisiónRESUMEN
BACKGROUND: A study was designed to assess a computer-based program for continuous registration of antibiotic resistance, statistics concerning severity of illness, and consumption of antibacterial drugs. METHODS: The frequency of antibiotic resistance among bacteria in eight ICUs in southeastern Sweden was investigated yearly from 1995 through 1997. The antibiotic consumption in the ICUs was registered as defined daily doses (DDD) and compared to severity of illness (APACHE-II scores). RESULTS: There was a statistically significant increase in ampicillin resistance among Enterococcus spp. between 1996 and 1997, which was due to a shift from Enterococcus faecalis to Enterococcus faecium. A high prevalence of resistance among coagulase-negative staphylococci to oxacillin (approximately 70%), ciprofloxacin (approximately 50%), fucidic acid (approximately 50%) and netilmicin (approximately 30%) was seen in all ICUs during the whole study period. There was a statistically significant increase in ciprofloxacin resistance among Escherichia coli and Enterococcus spp. The resistance among Enterobacter spp. to cefotaxime decreased but this change was not statistically significant. Efforts were made to avoid betalactam antibiotics, except carbapenems, for treatment of infections caused by Enterobacter spp. and the consumption of cephalosporins decreased whereas the consumption of carbapenems increased. The total antibiotic consumption decreased by 2.5% during the study period. There was no correlation between APACHE II scores and antibiotic consumption. CONCLUSIONS: Each ICU within a hospital ought to have a program for "on-line" antibiotic resistance surveillance of drugs used in that unit so that changes in empirical treatment can be made when there is an increase in antibiotic-resistant isolates within that unit.
Asunto(s)
Cuidados Críticos , Farmacorresistencia Microbiana , APACHE , Resistencia a la Ampicilina , Antibacterianos/uso terapéutico , Antiinfecciosos/uso terapéutico , Bacterias/clasificación , Bacterias/efectos de los fármacos , Carbapenémicos/uso terapéutico , Cefotaxima/uso terapéutico , Cefalosporinas/uso terapéutico , Ciprofloxacina/uso terapéutico , Utilización de Medicamentos , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecium/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Ácido Fusídico/uso terapéutico , Gentamicinas/uso terapéutico , Humanos , Netilmicina/uso terapéutico , Oxacilina/uso terapéutico , Resistencia a las Penicilinas , Penicilinas/uso terapéutico , Vigilancia de la Población , Prevalencia , Staphylococcus/efectos de los fármacos , SueciaRESUMEN
We studied sera from patients who had participated in a prospective study of borreliosis in Sweden and had acquired tick bites in areas of the country with a high prevalence of granulocytic ehrlichial infections in animals. The sera were examined for IgG anti Ehrlichia antibodies by an indirect immunofluorescence assay using a locally isolated bovine Ehrlichia antigen. Confirmation of the serological results was done at the Unité des Rickettsies, Marseille, France. Three out of 37 of the investigated patients and 1 out of 100 investigated healthy blood donors had significant antibody titres to granulocytotropic Ehrlichiae. No patient or blood donor had specific antibody titres to Ehrlichia chaffeensis. These data suggest that Scandinavian Ehrlichia species can infect and evoke immunological response in tick-exposed humans.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Ehrlichia/inmunología , Ehrlichiosis/inmunología , Enfermedad de Lyme/inmunología , Enfermedades por Picaduras de Garrapatas/inmunología , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Bovinos , Niño , Preescolar , Ehrlichia/clasificación , Ehrlichia/genética , Ehrlichiosis/epidemiología , Ehrlichiosis/microbiología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Inmunoglobulina G/sangre , Enfermedad de Lyme/epidemiología , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , Suecia/epidemiología , Enfermedades por Picaduras de Garrapatas/epidemiología , Enfermedades por Picaduras de Garrapatas/microbiologíaRESUMEN
The influence of thermal stimulation of the oral and pharyngeal mucosa on the elicitation of swallowing was studied in 14 healthy volunteers. The Repeated Dry Swallowing Test was used to study the ability to elicit swallows. The test consists of 11 manometrically recorded dry swallows performed at maximum speed. The time between swallows 1 and 11 (Swallowing Test Time) is considered a measure of the ease of eliciting the swallowing reflex. The study includes two controlled experiments, each consisting of an active test done immediately after a cold stimulus and a control done after a stimulus at body temperature. In one experiment the stimulus consisted of stimulation of the fauces with a laryngeal mirror and in the other of swallowing water. Each subject served as his or her own control. The order of the tests was randomized and the results read blindly. In the mirror experiment, the swallowing test times obtained after application of a cold laryngeal mirror did not differ significantly from those obtained after stimulation at body temperature. In the water experiment, swallowing test times were shorter after swallowing cold water compared to those after swallowing water at body temperature in 11 of the 14 volunteers (n.s.). The concept that swallowing is significantly facilitated by cold applied to the oral-pharyngeal mucosa was thus not supported by the present study. The importance of these findings is discussed.
Asunto(s)
Frío , Deglución/fisiología , Calor , Mucosa Bucal/fisiología , Faringe/fisiología , Adulto , Temperatura Corporal , Femenino , Humanos , Masculino , Manometría/instrumentación , Manometría/métodos , Manometría/estadística & datos numéricos , Persona de Mediana Edad , Estimulación Física/métodos , Valores de Referencia , Reflejo/fisiología , Estadísticas no Paramétricas , Factores de TiempoRESUMEN
Human ehrlichiosis diseases, decently recognised as emerging human infections in the USA, are caused by vector-borne, strictly intracellular bacteria of the family Rickettsiaceae. Human monocytic ehrlichiosis is caused by Ehrlichia schaffeensis, whereas the agent causing human granulocytic ehrlichiosis (HGE) has yet to be identified [1]. The putative increase in the occurrence of these primary zoonoses is dependent on the complex relationship between the infectious agents, the vectors, and the hosts (rodents, deer) which constitute the wild-life reservoir. In Scandinavia, granulocytic ehrlichiosis is well known in veterinary medicine. Pasture fever in cattle and sheep is caused by Ehrlichia phagocytophila, whereas granulocytic ehrlichiosis in horses and dogs is caused by a new, recently characterised Ehrlichia species [2]. All species of Ehrlichia causing granulocytic ehrlichiosis are closely related both genetically and antigenically, and are all transmitted by ticks of the genus Ixodes. In Sweden, veterinary cases of granulocytic ehrlichiosis are characterised by a geographical distribution corresponding well with that of Ixodes ricinus, and a seasonal distribution similar to that of Lyme borreliosis. In Europe, clinical cases of HGE have so far been reported only from Slovenia [5], though seroprevalence figures of 8-17 per cent have been reported for tick-exposed populations [6, 7]. As most cases are probably subclinical, and as clinical symptoms, when present, are non-specific, clinical diagnosis is dependent on the clinician's awareness of the existence of the disease. Laboratory diagnostic tests are now available at Kalmar.
Asunto(s)
Ehrlichiosis , Zoonosis , Animales , Bovinos , Vectores de Enfermedades , Perros , Ehrlichia chaffeensis/clasificación , Ehrlichia chaffeensis/genética , Ehrlichia chaffeensis/aislamiento & purificación , Ehrlichiosis/epidemiología , Humanos , Serotipificación , Suecia/epidemiologíaRESUMEN
We investigated the immune response to three different intracutaneous (i.c.) doses of inactivated hepatitis A vaccine: 72, 144, and 216 ELISA units (EU). The response was measured using a quotient score derived from a commercial enzyme-linked immunosorbent assay (HAVAB Abbott) and translated to IU per liter using a World Health Organization standard serum for hepatitis A virus antibody. The results were compared with the results obtained after an intramuscular (i.m.) full dose, i.e. 1,440 EU, at 0 and 6-12 months. As estimated from antibody concentration, 3 lots of 144 EU i.c. with 100% or two lots of 216 EU i.c. with 98% seroconversion results in at least as good early protection as the standard immunization with one lot of 1,440 EU i.m., (79% with our method). Indeed, only two doses of 144 EU vaccine (90% seroconversion) seem to give results comparable to the standard procedure. After the booster dose the median antibody concentration is 1,290 IU/l for the 144 EU vaccine and 837 for the 216 EU one, compared with an antibody response of 990 IU/l for the standard 1,440 EU i.m. vaccination. In conclusion, three doses of 144 EU vaccine i.c. or, as an alternative, two doses of 216 EU at monthly intervals give good early protection (e.g. before travel). After the booster dose, which is given 6 months to 1 year later, the serological response is comparable to the standard procedure of two doses of the 1,440 EU vaccine given i.m. and with 100% seroconversion in all three programs.
Asunto(s)
Virus de la Hepatitis A Humana/inmunología , Hepatitis A/prevención & control , Vacunación/economía , Vacunas contra Hepatitis Viral/administración & dosificación , Adolescente , Adulto , Anciano , Antígenos Virales/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Anticuerpos de Hepatitis A , Antígenos de Hepatitis A , Vacunas contra la Hepatitis A , Anticuerpos Antihepatitis/análisis , Humanos , Inyecciones Intradérmicas/métodos , Inyecciones Intramusculares/métodos , Masculino , Persona de Mediana Edad , Vacunas de Productos Inactivados/administración & dosificación , Vacunas de Productos Inactivados/efectos adversos , Vacunas de Productos Inactivados/economía , Vacunas contra Hepatitis Viral/efectos adversos , Vacunas contra Hepatitis Viral/economíaRESUMEN
Moraxella catarrhalis and Hemophilus influenzae are isolated from the nasopharynx in 50% to 55% and 8% to 15%, respectively, of cases of acute laryngitis in adults. This finding indicates that these organisms, M catarrhalis in particular, are in some way involved in the pathogenesis of the disorder. In the present double-blind, placebo-controlled trial, the effect of erythromycin ethylsuccinate (0.5 g twice a day for 5 days) on the elimination of nasopharyngeal pathogens and reduction of clinical signs of upper respiratory tract infection, as well as on subjective complaints, was evaluated in 106 adults with acute laryngitis. The bacterial isolation rates at presentation were M catarrhalis 50%, H influenzae 18%, and Streptococcus pneumoniae 4%. In the 99 patients who completed the study, the elimination of M catarrhalis after 1 week was better in the erythromycin group (25 of 30 cases) than in the placebo group (6 of 19 cases; p < or = .00038). The elimination of H influenzae was unaffected by erythromycin. Otolaryngologic examination did not reveal any significant group differences regarding laryngitis, pharyngitis, or rhinitis. Voice quality was improved after 1 week, irrespective of treatment. However, as compared to the placebo group, the erythromycin group reported fewer voice complaints after 1 week and fewer coughing complaints after 2 weeks. As acute laryngitis in adults is self-limiting, and subjective symptoms are spontaneously reduced after 1 week in most cases, antibiotic treatment does not seem warranted as a general policy. However, erythromycin may be justified in patients who are professionally dependent on voice function.
Asunto(s)
Etilsuccinato de Eritromicina/uso terapéutico , Infecciones por Haemophilus/tratamiento farmacológico , Haemophilus influenzae/aislamiento & purificación , Laringitis/tratamiento farmacológico , Moraxella catarrhalis/aislamiento & purificación , Infecciones por Neisseriaceae/tratamiento farmacológico , Enfermedad Aguda , Adulto , Método Doble Ciego , Femenino , Humanos , Laringitis/microbiología , Masculino , Nasofaringe/microbiologíaRESUMEN
We describe a case of life-threatening haemophagocytosis after a short term nutrition with fat emulsion in a 21-year-old woman who sustained an isolated traumatic brain injury. Hypertriglyceridemia and "creaming plasma" were observed after a three-day period of parenteral fat nutrition (Intralipid 20%). She also developed rash, high fever (40-41 degrees C), hypertension, raised intracranial pressure, hepatic and renal failure, haemolysis, marked thrombocyto- and leucopenia, coagulation disorder and pulmonary failure. These symptoms, together with a typical bone marrow smear, indicated haemophagocytosis with hyperactivation of the monocyte-macrophage system. We suggest that the hyperactivation was an effect of fat retention or agglutination of the fat particles; the initial triggering mechanism may emanate from the brain damage by hypercytokinaemia. The steroid treatment given most likely contributed to the successful outcome, as indicated by the stepwise improvement related in time to the steroid infusions.
Asunto(s)
Lesiones Encefálicas/terapia , Emulsiones Grasas Intravenosas/efectos adversos , Histiocitosis de Células no Langerhans/etiología , Insuficiencia Multiorgánica/etiología , Adulto , Alanina Transaminasa/sangre , Amilasas/sangre , Lesiones Encefálicas/complicaciones , Proteína C-Reactiva/análisis , Creatinina/sangre , Femenino , Fiebre/etiología , Histiocitosis de Células no Langerhans/sangre , Histiocitosis de Células no Langerhans/tratamiento farmacológico , Humanos , Recuento de Leucocitos , Metilprednisolona/uso terapéutico , Tiempo de Tromboplastina Parcial , Triglicéridos/sangreRESUMEN
In Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens strains isolated from clinical specimens in the south of Sweden two variants of beta-lactamase were distinguished by isoelectric focusing (IEF). The BRO-1 (Ravasio type) enzyme was the most common in Branhamella catarrhalis, constituting about 90% of the beta-lactamase found in this species, while the BRO-2 enzyme (1908 type) was as common as BRO-1 in Moraxella nonliquefaciens. The determinants mediating the production of BRO-1 and BRO-2 were both transferable by conjugation. Cell-bound beta-lactamase from reference strains producing BRO-1 and BRO-2 could be solubilized by papain digestion. The isoelectric point of the solubilized enzymes differed distinctly between BRO-1 (pI 6.5) and BRO-2 (pI 6.9). The molecular species of BRO-1 and BRO-2 released by papain digestion were purified by affinity chromatography with phenylboronic acid agarose gel. They had identical molecular weights of approximately 28,000. Their kinetic constants were indistinguishable for a number of substrates and beta-lactamase inhibitors.
Asunto(s)
Moraxella catarrhalis/enzimología , Moraxella/enzimología , beta-Lactamasas/metabolismo , Antibacterianos/metabolismo , Cromatografía de Afinidad , Conjugación Genética , Electroforesis en Gel de Agar , Punto Isoeléctrico , Cinética , Pruebas de Sensibilidad Microbiana , Peso Molecular , Papaína/metabolismo , Suecia , beta-Lactamasas/química , beta-Lactamasas/aislamiento & purificación , beta-LactamasRESUMEN
Sales of antibiotics have increased in Sweden during the past decade. This has been paralleled by an increase in the frequency of beta-lactamase-producing respiratory tract bacteria. To investigate the effects of regional differences in use of antibiotics on beta-lactamase production in respiratory tract bacteria, we collected nasopharyngeal specimens and information about antibiotic use from 1133 children attending day-care centres in four rural municipalities with low use, and one urban municipality with high use of antibiotics, use being assessed from pharmacy sales. The frequency of beta-lactamase production among isolates of Branhamella catarrhalis and Moraxella nonliquefaciens was significantly higher in the urban municipality. This appeared to be a long-term ecological effect of differences in the level of use of antibiotics between the urban and rural populations, rather than an effect of recent antibiotic treatment of individual patients.
Asunto(s)
Antibacterianos/farmacología , Haemophilus influenzae/fisiología , Moraxella catarrhalis/fisiología , Moraxella/fisiología , Nasofaringe/microbiología , beta-Lactamasas/metabolismo , Antibacterianos/uso terapéutico , Guarderías Infantiles , Preescolar , Haemophilus influenzae/efectos de los fármacos , Haemophilus influenzae/aislamiento & purificación , Humanos , Moraxella/efectos de los fármacos , Moraxella/aislamiento & purificación , Moraxella catarrhalis/efectos de los fármacos , Moraxella catarrhalis/aislamiento & purificación , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/microbiología , Población Rural , Suecia , Población UrbanaRESUMEN
Background factors, symptoms and signs were analysed in 40 consecutive patients with psychogenic dysphonia. Their voice profile was compared with that of 40 patients with infectious laryngitis. The majority of the patients were young females, non-smokers, who were not professional voice users. Criteria for acute infectious laryngitis prior the voice disorder were met in no more than 10% of the patients. Nevertheless as many as 40% of the patients had been treated with various antibiotics. The prevalence of reported asthma/allergy-like symptoms was high, 37.5%. Perceptual analysis of voice profiles demonstrated similarity of aberrancies in psychogenic dysphonia and in acute laryngitis. Since it may be difficult to distinguish psychogenic dysphonia from acute laryngitis, careful analysis of anamnestic data may be helpful for a correct diagnosis.
Asunto(s)
Trastornos de la Voz/diagnóstico , Enfermedad Aguda , Adolescente , Adulto , Niño , Femenino , Humanos , Laringitis/diagnóstico , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estrés Psicológico/complicaciones , Trastornos de la Voz/psicologíaRESUMEN
Previous studies of acute laryngitis in adults have shown high nasopharyngeal isolation rates of B. catarrhalis and H. influenzae. Phenoxymethylpenicillin had no effect on the clinical course. In the present study, 106 patients with acute laryngitis were treated with erythromycin 0.5 g x 2 V or placebo. During the first week the isolation rate of B. catarrhalis was reduced from 60 to 10% in the erythromycin group compared to 34 to 27% in the placebo group (p less than 0.01). The elimination of H. influenzae, isolated in 19% at the acute visit, did not differ between the two groups. As compared to controls, erythromycin treated patients reported significantly lower scores of subjective voice disturbance after 1 week and cough after 2 weeks. Laryngological examination and voice evaluation failed to reveal any differences between the groups.
Asunto(s)
Eritromicina/uso terapéutico , Laringitis/tratamiento farmacológico , Enfermedad Aguda , Adolescente , Adulto , Diagnóstico Diferencial , Método Doble Ciego , Haemophilus influenzae/aislamiento & purificación , Humanos , Laringitis/diagnóstico , Laringitis/microbiología , Moraxella catarrhalis/aislamiento & purificación , Nasofaringe/microbiología , Infecciones del Sistema Respiratorio/microbiología , Calidad de la VozRESUMEN
PURPOSE: To assess the ecologic impact, in terms of selection of beta-lactamase-producing respiratory tract bacteria, of a single course of peroral beta-lactam antibiotics. PATIENTS AND METHODS: One-hundred fifty consecutive children with clinical signs of bacterial respiratory tract infection were randomly assigned to a seven-day course of treatment with either penicillin V, amoxicillin, or cefaclor. Bacteriologic specimens were collected before treatment, at its termination, and at follow-up four weeks later. RESULTS: All three drugs investigated caused a similar increase in beta-lactamase-producing bacteria, both in absolute and relative terms, an increase that persisted over a period of at least one month after completion of treatment. CONCLUSION: Penicillin V, amoxicillin, and cefaclor all act as selective agents for beta-lactamase-producing bacteria in the upper respiratory tract. Treatment with a peroral beta-lactam antibiotic puts patients at risk of becoming persistent carriers of beta-lactamase-producing bacteria.